- Research works
- 74 ▲ 79% vs 2018-21
- Citations
- 4k 54.7 per fractional work
- Top-10% rate
- 17.2% all institutions 10.0%
- Open access
- 44% world 40%
- International
- 33% world 18%
Not ranked overall: Esperion Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.
Which fields of science does Esperion Therapeutics (United States) work in?
In 2022-now, 73% of research at Esperion Therapeutics (United States) is in Health Sciences, 20% in Life Sciences. Its largest fields are Medicine (73%), Biochemistry, Genetics and Molecular Biology (14%), Immunology and Microbiology (5%). It does 2.4× the world's share of Health Sciences.
Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.
Its 4 domains and 10 fields, with their numbers
- Health Sciences1973.4%
- Life Sciences520.2%
- Physical Sciences14.8%
- Mathematics14.2%
- Engineering00.7%
- Social Sciences01.5%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.6×. Every wedge is a field page.
All 10 fields, with their numbers
- Immunology and Microbiology4.64×1 works
- Medicine3.78×18 works
- Mathematics3.53×1 works
- Pharmacology, Toxicology and Pharmaceutics3.41×0 works
- Biochemistry, Genetics and Molecular Biology2.60×4 works
- Nursing1.54×0 works
- Economics, Econometrics and Finance0.56×0 works
- Agricultural and Biological Sciences0.10×0 works
- Business, Management and Accounting0.10×0 works
- Engineering0.04×0 works
- Immunology and Microbiology 4.6×
- Medicine 3.8×
- Mathematics 3.5×
- Pharmacology, Toxicology and Pharmaceutics 3.4×
- Biochemistry, Genetics and Molecular Biology 2.6×
- Nursing 1.5×
- Economics, Econometrics and Finance 0.6×
- Agricultural and Biological Sciences 0.1×
- Business, Management and Accounting 0.1×
- Engineering 0.0×
Who are the top researchers at Esperion Therapeutics (United States)?
Ranked on the quality score, LeAnne T. Bloedon, Roger S. Newton and Stephen L. Pinkosky lead among researchers whose main affiliation is Esperion Therapeutics (United States).
- 1
LeAnne T. Bloedon
United States · #185,386 worldwide 7.3k citations · 82 works
- 2
Roger S. Newton
United States · #227,966 worldwide 8k citations · 119 works
- 3
Stephen L. Pinkosky
United States · #289,652 worldwide 2.5k citations · 28 works
- 4
Jeffrey Christian Hanselman
United States · #314,896 worldwide 3k citations · 50 works
- 5
Diane Elaine MacDougall
United States · #369,613 worldwide 2.8k citations · 63 works
- 6
Charles L. Bisgaier
United States · #617,204 worldwide 5.3k citations · 71 works
- 7
Janice Rose Margulies
United States · #650,292 worldwide 1.1k citations · 18 works
- 8
Sergey Ivanovich Filippov
United States · #1,565,127 worldwide 1.8k citations · 41 works
- 9
Evelyn Sarnes
United States · #1,815,352 worldwide 489 citations · 24 works
- 10
Clay T. Cramer
United States · #1,909,053 worldwide 1.4k citations · 33 works
Which keywords describe research at Esperion Therapeutics (United States)?
By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Statins, Clinical Trials, Cardiovascular Disease Prevention, C-Reactive Protein, Cholesterol-lowering, LDL Cholesterol and Atherosclerosis.
- Prognostic Factors
- Systemic Lupus Erythematosus
- Global Prevalence
- Antiphospholipid Syndrome
- Glucose Metabolism
- Cancer
- Diabetes
- Insulin Resistance
- Metabolic Syndrome
- Atherosclerosis
- Cholesterol-lowering
- Cardiovascular Disease Prevention
- Statins
- Inflammation
- Clinical Trials
- C-Reactive Protein
- LDL Cholesterol
- Cardiovascular Disease
- Cholesterol
- Obesity
- Oxidative Stress
- Autoantibodies
- Metabolism
- Cardiovascular Risk
- Lifestyle Intervention
- Macrophage
- Quality of Life
Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 27 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 27 words, with their numbers
- Inflammation4▲ 8.2×22 topics
- Statins4▲ 218×2 topics
- Clinical Trials4▲ 23×5 topics
- Cardiovascular Disease Prevention4▲ 163×2 topics
- C-Reactive Protein4▲ 184×2 topics
- Cholesterol-lowering3▲ 293×1 topic
- LDL Cholesterol3▲ 395×1 topic
- Atherosclerosis3▲ 44×6 topics
- Cardiovascular Disease3▲ 10.0×9 topics
- Metabolic Syndrome3▲ 14×9 topics
- Cholesterol2▲ 68×3 topics
- Insulin Resistance2▲ 20×5 topics
- Obesity2▲ 10×7 topics
- Diabetes2▲ 14×4 topics
- Oxidative Stress2▲ 3.6×7 topics
- Cancer1▲ 3.7×8 topics
- Autoantibodies1▲ 20×2 topics
- Glucose Metabolism1▲ 47×2 topics
- Metabolism1▲ 8.9×4 topics
- Antiphospholipid Syndrome1▲ 90×1 topic
- Cardiovascular Risk1▲ 13×5 topics
- Global Prevalence1▲ 44×1 topic
- Lifestyle Intervention1▲ 48×1 topic
- Systemic Lupus Erythematosus1▲ 80×1 topic
- Macrophage1▲ 52×2 topics
- Prognostic Factors1▲ 9.3×3 topics
- Quality of Life1▲ 2.8×2 topics
Which research topics does Esperion Therapeutics (United States) publish most on?
By volume in 2022-now: Lipoproteins and Cardiovascular Health, Systemic Lupus Erythematosus Research, Diabetes, Cardiovascular Risks, and Lipoproteins and Cancer Treatment and Pharmacology.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Lipoproteins and Cardiovascular Health Surgery 3 works
- 2 Systemic Lupus Erythematosus Research Rheumatology 1 works
- 3 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 1 works
- 4 Cancer Treatment and Pharmacology Oncology 1 works
- 5 Chronic Lymphocytic Leukemia Research Genetics 1 works
- 6 Cholesterol and Lipid Metabolism Surgery 1 works
- 7 Cancer, Lipids, and Metabolism Cancer Research 1 works
- 8 HIV-related health complications and treatments Emergency Medicine 1 works
- 9 Atherosclerosis and Cardiovascular Diseases Immunology 0 works
- 10 Liver Disease Diagnosis and Treatment Epidemiology 0 works
How open and international is its research?
Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 40% of research is openly available.
World: 18% is written across borders.
How has Esperion Therapeutics (United States)'s research output changed?
Output in 2022-2025 was 79% higher than in 2018-2021.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Esperion Therapeutics (United States) as a percentage of every work published that year, 0.000065% in 2024.
Fractional works of Esperion Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.
Other research institutions in Ann Arbor
- University of Michigan
- Ann Arbor Center for Independent Living
- C. S. Mott Children's Hospital
- Environmental Research Institute of Michigan
- Women's Hospital
- A. Alfred Taubman Health Care Center
- Michigan Center for Translational Pathology
- U-M Rogel Cancer Center
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.
Discussion
Ask a question or share a note about Esperion Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.